medigraphic.com
ISSN 1029-3035 (Electronic)

2017, Number 2

<< Back Next >>

Mediciego 2017; 23 (2)

Stem cells. Overview (Part I)

Camacho AJA, Camacho EL, Gómez MN, Camacho AV, López BK, García GH

Language: Spanish
References: 38
Page: 71-85
PDF size: 559.08 Kb.


ABSTRACT

Introduction: advances in the knowledge of stem cell biology and the molecular mechanisms that regulate self-renovation and cellular differentiation allow the emergence of new therapeutic options for various diseases that, so far, do not have effective treatments.
Objective: to collect in a structured form information regarding stem cells, embryonic and adult, their sources of production, potentialities, versatility and mechanisms of action.
Method: the national and international literature on the subject, published mainly between 2011 and 2015 in Spanish and English, in print and digital formats was reviewed. The Internet search included the Medline, CUMED and SciELO Cuba databases; "Stem cells", "pluripotential cells", "regenerative medicine" and "tissue engineering" were used as search criteria. A structured review was prepared from the selected materials.
Development: stem cells have the ability to self-replicate indefinitely by cell division (selfrenewal) and under appropriate microenvironmental conditions can morphologically and functionally differentiate into other specialized cell types. Various investigations in animal models and observations in humans show that adult stem cells can contribute to the regeneration of damaged tissues.
Conclusions: the exclusive properties of stem cells and their biological behavior open up promising perspectives in basic and clinical research with a view to their therapeutic use in various diseases. However, there is a need to delve deeper into the mechanisms of stem cell renewal, differentiation and action, to agree on research results and to establish clinical recommendations based on scientific evidence.


REFERENCES

  1. Mason C, Dunnill P. A brief definition of regenerative medicine. Regen Med [Internet]. 2008 [citado 3 Mar 2016];3(1):1-5. Disponible en: http://regmedvienna.es/images/Fuer- Experten_Literatur/A-brief-definition-of-regenerative-medicine.pdf

  2. Hernández Ramírez P. Décimo aniversario del fructífero empleo de la medicina regenerativa en Cuba. Rev Cubana Hematol Inmunol Hemoter [Internet]. Sep 2015 [citado 23 May 2016];31(3):221-5. Disponible en: http://scielo.sld.cu/pdf/hih/v31n3/hih01315.pdf

  3. Hernández P, Dorticós E. Medicina regenerativa. Células madre embrionarias y adultas. Rev Cubana Hematol Inmunol Hemoter [Internet]. Dic 2004 [citado 3 Mar 2016];20(3):[aprox. 6 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864- 02892004000300001

  4. Daley GQ, Goodell MA, Snyder EY. Realistic prospects for stem cell therapeutics. Hematology [Internet]. 2003 [citado 5 Abr 2016];1:398-418. Disponible en: http://asheducationbook.hematologylibrary.org/content/2003/1/398.full.pdf

  5. Miranda M, Vázquez G, Sánchez V. Generalidades y aplicaciones de las células madre. Perinatol Reprod Hum [Internet]. Ene 2013 [citado 5 Abr 2016];27(3):194-9. Disponible en: http://www.scielo.org.mx/pdf/prh/v27n3/v27n3a9.pdf

  6. Prósper F, Gavira J, Herreros J, Rábago G, Luquin R, Moreno J, et al. Trasplante celular y terapia regenerativa con células madre. Anales Sis San Navarra [Internet]. Ago 2006 [citado 5 Abr 2016];29 Supl 2:219-34. Disponible en: http://scielo.isciii.es/pdf/asisna/v29s2/original17.pdf

  7. Pérez J, Casado F. Células madre: limitaciones y oportunidades en el Perú. Rev perú med exp salud publica [Internet]. Oct 2015 [citado 5 Abr 2016];32(4):[aprox. 9 p.]. Disponible en: http://www.scielo.org.pe/scielo.php?pid=S1726- 46342015000400022&script=sci_arttext&tlng=pt

  8. Hug K. Sources of human embryos for stem cell research: ethical problems and their possible solution. Medicine (Kaunas) [Internet]. 2005 [citado 5 Abr 2016];41(12):1002-10. Disponible en: http://medicina.lsmuni.lt/med/0512/0512-02e.pdf

  9. González Espinoza CR. Células madre, aspectos éticos y jurídicos II. Docentia et Investigatio [Internet]. 2013 [citado 5 Abr 2016];15(2):75-85. Disponible en: http://revistasinvestigacion.unmsm.edu.pe/index.php/derecho/article/viewFile/10626/9436

  10. Brazzini Arméstar A. Células Madre Adultas Autólogas. Aplicaciones y experiencias clínicas. Lima: Amolca; 2015.

  11. Chen CW, Corcelli M, Péault B, Huard J. Human blood-vessel derived stem cells for tissue repair and regeneration. J Biomed Biotech [Internet]. 2012 [citado 5 Abr 2016];2012:[aprox. 9 p.]. Disponible en: http://downloads.hindawi.com/journals/biomed/2012/597439.pdf

  12. Brunt KR, Weisel RD, Li RK. Stem cell and regenerative medicine future perspectives. Can J Physio lPharmacol [Internet]. 2012 [citado 5 Abr 2016];90:327-35. Disponible en: https://www.researchgate.net/profile/Keith_Brunt/publication/43160121_Temporal_and_Spat ial_Regulation_of_Histone_Deacetylase-7_and_b- Catenin_in_Endothelial_Cells/links/0a85e536d47cdb14c5000000.pdf

  13. Hernández Ramírez P, Alfonso Simón A, Aparicio Suárez JL, Artaza Sanz H, Baganet Cobas A, Blanco Díaz A, et al. Experiencia cubana con el uso terapéutico de células madre adultas. Rev Cubana Hematol Inmunol Hemoter [Internet]. Mar 2011 [citado 1 Abr 2015];27(1):139-63. Disponible en: http://scielo.sld.cu/pdf/hih/v27n1/hih12111.pdf

  14. Hernández Ramírez P. Hitos y perspectivas de la terapia celular en Cuba. Rev Cubana Hematol Inmunol Hemoter [Internet]. Sep 2014 [citado 5 Abr 2016];30(3):298-303. Disponible en: http://scielo.sld.cu/pdf/hih/v30n3/hih14314.pdf

  15. Hernández-Ramírez P. Reflexiones sobre la introducción y desarrollo de la terapia celular en Cuba. Rev Cubana Hematol Inmunol Hemoter [Internet]. Sep 2013 [citado 5 Abr 2016];29(3):304-6. Disponible en: http://scielo.sld.cu/pdf/hih/v29n3/hih11313.pdf

  16. Hayden EC, Baker M. Virus-free pluripotency for human cells. Stem-cell advance could bring tailored treatments closer. Nature. Mar 2009;458(7234):19.

  17. Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA. In vivo reprogramming of adult pancreatic exocrine cells to a cells. Nature [Internet]. 2008 [citado 5 Abr 2016];455:627-32. Disponible en: http://www.nature.com/nature/journal/v455/n7213/full/nature07314.html

  18. Power C, Rasko J. Will Cell Reprogramming resolve the embryonic stem cell controversy? A Narrative Review. Ann Intern Med. 2011;155(2):114-21.

  19. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell [Internet]. Nov 2007 [citado 5 Abr 2016];131(5):[aprox. 12 p.]. Disponible en: http://www.stemcells.nrw.de/fileadmin/media/documents/Aktuelles/Takashi_Yamanaka.pdf

  20. Bar Nur O, Russ HA, Efrat S, Benvenisty N. Epigenetic memory and preferential lineagespecific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. Cell Stem Cell [Internet]. Jul 2011 [citado 5 Abr 2016];9(1):17-23. Disponible en: http://ac.els-cdn.com/S1934590911002931/1-s2.0-S1934590911002931- main.pdf?_tid=767ee33a-40b4-11e7-a30a- 00000aab0f6c&acdnat=1495653128_8c9b73af361684643fbecfd4232070be

  21. Tachibana M, Amato P, Sparman M, Gutiérrez NM, Tippner Hedges R, Hong M, et al. Human embryonic stem cells derived by somatic cell nuclear transfer. Cell [Internet]. Jun 2013 [citado 5 Abr 2016];153(6):1228-38. Disponible en: http://ac.elscdn. com/S0092867413005710/1-s2.0-S0092867413005710-main.pdf?_tid=f6dc39b4-40b5- 11e7-9042-00000aab0f02&acdnat=1495653773_0ef04c7fb43529822995a7d1fa367387

  22. Orbay H, Tobita M, Mizuno H. Mesenchymal stem cell isolated from adipose and other tissues: basic biological properties and clinical applications. Stem cells Int [Internet]. 2012 [citado 5 Abr 2016];2012:[aprox. 9 p.]. Disponible en: http://downloads.hindawi.com/journals/sci/2012/461718.pdf

  23. Blasco Morente G, Arias Santiago S. Aplicaciones de células madre en dermatología. Más Dermatol [Internet]. 2014 [citado 5 Abr 2016];22:4-13. Disponible en: http://www.masdermatologia.com/PDF/0140.pdf

  24. Cortina L, Hernández P, López De Roux MR, Artaza HM, Dorticós E, Macías C, et al. Aislamiento de células mononucleares de sangre periférica para trasplante de células madre: método simplificado. Rev Cubana Hematol Inmunol Hemoter [Internet]. Dic 2008 [citado 5 Abr 2016];24(3):[aprox. 9 p.]. Disponible en: Disponible en: http://scielo.sld.cu/pdf/hih/v24n3/hih04308.pdf

  25. Rigacci L. Feasibility and safety of a reduced duration of therapy of colony stimulating factor in a dose-dense regimen. Support Care Cancer [Internet]. 2014 [citado 5 Abr 2016];22:2557- 61. Disponible en: http://download.springer.com/static/pdf/616/art%253A10.1007%252Fs00520-014-2237- 9.pdf?originUrl=http%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs00520-014- 2237- 9&token2=exp=1495656923~acl=%2Fstatic%2Fpdf%2F616%2Fart%25253A10.1007%2525 2Fs00520-014-2237- 9.pdf%3ForiginUrl%3Dhttp%253A%252F%252Flink.springer.com%252Farticle%252F10.1007 %252Fs00520-014-2237- 9*~hmac=20f3f144a318728f2d5953b202697ee264fc206280cb24587daf64e524e3426e

  26. Crobu D, Spinetti G, Schrepfer R, Tonon G, Saccani G, Onali P. Preclinical and clinical phase I studies of a new recombinant Filgrastim (BK0023) in comparisonwith Neupogen®. BMC Pharmacology and Toxicology [Internet]. Feb 2014 [citado 5 Abr 2016];15:7. Disponible en: http://www.biomedcentral.com/2050-6511/15/7

  27. Álvarez P. Regulatory Systems in Bone Marrow for Hematopoietic Stem/Progenitor Cells Mobilization and Homing. BioMed Research International [Internet]. May 2013 [citado 5 Abr 2016];2013:[aprox. 12 p.]. Disponible en: http://downloads.hindawi.com/journals/bmri/2013/312656.pdf

  28. Ferrer B. Comparación de la actividad de 2 factores estimuladores de colonias de granulocitos de producción nacional: Hebervital y Leukocim. Rev Cubana Hematol Inmunol Hemoter [Internet]. Dic 2011 [citado 5 Abr 2016];27(4):429-39. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892011000400007

  29. Eaves CJ. Hematopoietic stem cells: concepts, definitions, and the new reality. Blood [Internet]. Abr 2015 [citado 5 Abr 2016];125(17):2605-13. Disponible en: http://www.bloodjournal.org/content/bloodjournal/125/17/2605.full.pdf

  30. Rodríguez A, Cabrera J, Delgado J. Propiedades inmunomoduladoras de las células madre mesenquimales. Rev Cubana Hematol Inmunol Hemoter [Internet]. Mar 2015 [citado 5 Abr 2016];31(1):20-31. Disponible en: http://scielo.sld.cu/pdf/hih/v31n1/hih03115.pdf

  31. Ferrer B. Células madre mesenquimales: aspectos relevantes y aplicación clínica en la medicina regenerativa. Rev Cubana Hematol Inmunol Hemoter [Internet]. Mar 2013 [citado 5 Abr 2016];29(1):16-23. Disponible en: http://scielo.sld.cu/pdf/hih/v29n1/hih03113.pdf

  32. Hernández P. Medicina regenerativa y células madre. Mecanismos de acción de las células madre adultas. Rev Cubana Hematol Inmunol Hemoter [Internet]. Abr 2009 [citado 5 Abr 2016];25(1):[aprox. 9 p.]. Disponible en: http://scielo.sld.cu/pdf/hih/v25n1/hih02109.pdf

  33. Stangeland B, Mughal AA, Grieg Z, Sandberg CJ, Joel M, Nygård S, et al. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells. Oncotarget [Internet]. Sep 2015 [citado 5 Abr 2016];22;6(28):26192-215. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694895/pdf/oncotarget-06-26192.pdf

  34. Kreso A, Dick JE. Evolution of the cancer stem cell model. Cell Stem Cell [Internet]. Mar 2014 [citado 5 Abr 2016];14(3):275-91. Disponible en: http://ac.elscdn. com/S1934590914000575/1-s2.0-S1934590914000575-main.pdf?_tid=5b313dc0-4227- 11e7-9616-00000aacb35d&acdnat=1495812426_9043a8eaaaa7af026174b7f0e048b7a1

  35. Medema JP, Vermeulen L. Microenvironmental regulation of stem cells in intestinal homeostasis and cancer. Nature [Internet]. Jun 2011 [citado 5 Abr 2016];474(7351):318-26. Disponible en: http://www.nature.com/nature/journal/v474/n7351/pdf/nature10212.pdf

  36. Brooks MD, Burness ML, Wicha MS. Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer. Cell Stem Cell [Internet]. Sep 2015 [citado 5 Abr 2016];17(3):260-71. Disponible en: http://ac.els-cdn.com/S1934590915003690/1-s2.0- S1934590915003690-main.pdf?_tid=fbf2c598-446c-11e7-ae6d- 00000aab0f02&acdnat=1496062233_5c82a268927a55c52547165e5dab420e

  37. Rycaj K, Tang DG. Cell-of-Origin of Cancer versus Cancer Stem Cells: Assays and Interpretations. Cancer Res [Internet]. Oct 2015 [citado 5 Abr 2016];75(19):4003-11. Disponible en: http://cancerres.aacrjournals.org/content/canres/75/19/4003.full.pdf

  38. McCarthy N. Cancer stem cells: Tracing clones. Nat Rev Cancer [Internet]. Sep 2012 [citado 5 Abr 2016];12(9):579. Disponible en: http://search.proquest.com/openview/381520f8e37a913c9d26ce61bc17ee3c/1?pqorigsite=gscholar&cbl=27578




2020     |     www.medigraphic.com